BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/24/2021 2:07:00 AM | Browse: 297 | Download: 721
 |
Received |
|
2021-03-05 08:37 |
|
Peer-Review Started |
|
2021-03-05 08:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-24 04:14 |
|
Revised |
|
2021-04-27 11:54 |
|
Second Decision |
|
2021-07-15 03:23 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-07-15 06:31 |
|
Articles in Press |
|
2021-07-15 06:31 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-09 02:05 |
|
Publish the Manuscript Online |
|
2021-08-24 02:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Respiratory System |
| Manuscript Type |
Case Report |
| Article Title |
Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
So-My Koo, Ki-Up Kim, Yang-Ki Kim and Soo-Taek Uh |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Soonchunhyang University Research Fund |
|
|
| Corresponding Author |
Ki-Up Kim, MD, Professor, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, 59 Daesakwan-Ro, Yongsan-Ku, Seoul 04401, South Korea. kukim@schmc.ac.kr |
| Key Words |
Acute myeloid leukemia; Erlotinib; Neoplasm, second primary; Non-small cell lung cancer; Case report |
| Core Tip |
Therapy-related acute myeloid leukemia (t-AML) developed during erlotinib treatment in a patient with epidermal growth factor receptor (EGFR)–mutant advanced non-small cell lung cancer (NSCLC). Alkylating cytotoxic drugs and radiotherapy are common treatments for patients with NSCLC. Cases of t-AML related to alkylating agents typically have a long latency period. Since it was 20 mo in this case, EGFR–tyrosine kinase inhibitor (EGFR-TKI) usage may be related to or hasten AML development in patients who previously received cytotoxic chemotherapy. Although the mechanism remains unclear, when a patient takes an EGFR-TKI, t-AML development should be considered, especially if cytopenia persists. |
| Publish Date |
2021-08-24 02:07 |
| Citation |
Koo SM, Kim KU, Kim YK, Uh ST. Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report. World J Clin Cases 2021; 9(24): 7205-7211 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i24/7205.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i24.7205 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
